Cullinan Therapeutics, Inc.
Cullinan Therapeutics, Inc. (CGEM) stock FAQs
Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.
What is Cullinan Therapeutics, Inc. (CGEM) stock price today?
As of Dec 16, 2025, 6:48 PM UTC, Cullinan Therapeutics, Inc. (CGEM) stock is trading at $10.23. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date CGEM stock quotes for informed trading decisions.
What is Cullinan Therapeutics, Inc.'s market capitalization?
Cullinan Therapeutics, Inc. (CGEM) has a market capitalization of approximately $604.3M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Cullinan Therapeutics, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the CGEM stock price changes.
What is the 52-week range for Cullinan Therapeutics, Inc. stock?
Cullinan Therapeutics, Inc. (CGEM) stock has traded in a 52-week range of $5.68 — $13.33. The 52-week range shows the highest and lowest prices at which CGEM traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Cullinan Therapeutics, Inc. stock price to this range provides context for recent price action.
How much trading volume does Cullinan Therapeutics, Inc. stock have?
Cullinan Therapeutics, Inc. (CGEM) stock recently traded approximately 676.5K shares. Trading volume indicates market liquidity and investor interest in CGEM. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Cullinan Therapeutics, Inc. stock.
Does Cullinan Therapeutics, Inc. pay dividends to shareholders?
Yes, Cullinan Therapeutics, Inc. (CGEM) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Cullinan Therapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.
What is Cullinan Therapeutics, Inc.'s intraday price range?
Today, Cullinan Therapeutics, Inc. (CGEM) stock has traded in a range of $10.08 — $10.94. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring CGEM's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.
Where does AlphaPilot get Cullinan Therapeutics, Inc. stock data?
AlphaPilot sources real-time CGEM stock quotes, fundamental financial data, and historical price charts for Cullinan Therapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Cullinan Therapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of CGEM stock performance.